Celldex Therapeutics, Inc. License Costs (Deprecated 2018-01-31)
Celldex Therapeutics, Inc. (CLDX) reported License Costs (Deprecated 2018-01-31) of $700.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LicenseCosts · last filed 2018-03-07
- Celldex Therapeutics, Inc. license costs (deprecated 2018-01-31) for fiscal 2017 was $700.00K, a 56.25% decline from fiscal 2016.
- Celldex Therapeutics, Inc. license costs (deprecated 2018-01-31) for fiscal 2016 was $1.60M, a 77.78% increase from fiscal 2015.
- Celldex Therapeutics, Inc. license costs (deprecated 2018-01-31) for fiscal 2015 was $900.00K.
| Period end | License Costs (Deprecated 2018-01-31) 12 month |
|---|---|
| 2017-12-31 | $700.00K 10-K · filed 2018-03-07 |
| 2016-12-31 | $1.60M 10-K · filed 2018-03-07 |
| 2015-12-31 | $900.00K 10-K · filed 2018-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |